Solomon, Yenealem
Malkamu, Birhanemaskal
Berhan, Ayenew
Eyayu, Tahir
Almaw, Andargachew
Legese, Biruk
Woldu, Berhanu
Article History
Received: 19 October 2022
Accepted: 11 March 2023
First Online: 22 March 2023
Declarations
:
: Ethical clearance was obtained from the ethical review committee of the School of Biomedical and Laboratory Science, College of Medicine and Health Sciences, University of Gondar, on March 3, 2021, with letter reference number SBMLS-2748. The Department of Hematology and Immunohematology provided a support letter, which was forwarded to the directors of UGCSH and TGSH. In addition, a permission letter to conduct research was obtained from the UGCSH and TGSH directors.Informed written consent was obtained from each study participant after the objective of the study was explained. For illiterate patients, informed consent was obtained after objective of study and detailed information was read by data collectors. Then fingerprint signature was taken from each illiterate study participant and this prcedure was approved by ethical review committee of the School of Biomedical and Laboratory Science, College of Medicine and Health Sciences, University of Gondar. Study participants were identified by using codes rather than individual identifiers. The results and information of the study participants were kept confidential. Study participants who had elevated eosinophil counts were linked to the UGCSH and TGSH chronic outpatient departments for proper management. All methods were performed per the relevant guidelines and regulations (Declaration of Helsinki).
: Not applicable.
: The authors have no conflict of interest to declare.